Elisabeth Widén
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery top 5%
- Genetics top 5%
- Physiology top 5%
- Co-authors
- Johan G. ErikssonCarola SalorantaAgneta EkstrandA. Franssila-KallunkiPer‐Henrik GroopLeif GroopJuha KereSari Koskenmies
- Topics
- Metabolism, Diabetes, and Cancer (7 papers)Muscle metabolism and nutrition (5 papers)Diet and metabolism studies (5 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Clinical Investigation
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Elisabeth Widén
29 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 922
- Endocrinology, Diabetes and Metabolism 740
- Surgery 625
- Genetics 543
- Physiology 526
Countries citing papers authored by Elisabeth Widén
This map shows the geographic impact of Elisabeth Widén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Widén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Widén more than expected).
Fields of papers citing papers by Elisabeth Widén
This network shows the impact of papers produced by Elisabeth Widén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Widén. The network helps show where Elisabeth Widén may publish in the future.
Co-authorship network of co-authors of Elisabeth Widén
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Widén. A scholar is included among the top collaborators of Elisabeth Widén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Widén. Elisabeth Widén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 4 | |
| 3 | 29 | |
| 4 | 23 | |
| 5 | 64 | |
| 6 | 30 | |
| 7 | 453 | |
| 8 | 18 | |
| 9 | 115 | |
| 10 | 118 | |
| 11 | 61 | |
| 12 | 1 | |
| 13 | 109 | |
| 14 | 168 | |
| 15 | 121 | |
| 16 | 1 | |
| 17 | 8 | |
| 18 | Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy? | 20 |
| 19 | Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitusbreakdown → | 666 |
| 20 | 50 |
About Elisabeth Widén
Elisabeth Widén is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Physiology, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (7 papers), Muscle metabolism and nutrition (5 papers) and Diet and metabolism studies (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (740 citations), Rheumatology (363 citations) and Immunology (447 citations). Elisabeth Widén has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Johan G. Eriksson, Carola Saloranta, Agneta Ekstrand, A. Franssila-Kallunki, Per‐Henrik Groop, Leif Groop, Juha Kere, Sari Koskenmies, Heikki Julkunen and L. Groop. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.